IR@PKUHSC  > 北京大学第二临床医学院  > 血液科
学科主题临床医学
Haploidentical stem cell transplantation in patients aged 50yr and older with leukemia: similar outcomes compared to younger adults
Chen, Yao1; Wang, Yu1; Xu, Lan-Ping1; Liu, Kai-Yan1; Chen, Huan1; Chen, Yu-Hong1; Zhang, Xiao-Hui1; Wang, Feng-Rong1; Han, Wei1; Wang, Jing-Zhi1; Yan, Chen-Hua1; Zhang, Yuan-Yuan1; Sun, Yu-Qian1; Huang, Xiao-Jun1,2
关键词Age Haploidentical Hla Leukemia Stem Cell Transplantation
刊名CLINICAL TRANSPLANTATION
2015-06-01
DOI10.1111/ctr.12545
29期:6页:523-530
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Surgery ; Transplantation
研究领域[WOS]Surgery ; Transplantation
关键词[WOS]VERSUS-HOST-DISEASE ; BONE-MARROW-TRANSPLANTATION ; RISK-FACTORS ; CONDITIONING REGIMEN ; IMMUNE-SYSTEM ; T-CELLS ; BLOOD ; DEPLETION ; DONOR ; MALIGNANCIES
英文摘要

AimWe aimed to analyze the complications and survival associated with myeloablative haploidentical SCT in patients aged 50yr and compare these results with a younger group population.

Design and methodsIn this case-control study, enrolled patients with leukemia were identified from 1262 patients between May 2002 and May 2013 at a single institution.

ResultsThirty-one patients were aged 50yr (the older group) and 165 patients were aged 18-49yr (the younger group). Of the older group, 20 of 31 (64.5%) had a hematopoietic cell transplantation comorbidity index (HCT-CI) of 0 or 2. Statistical analysis showed no significant differences in the incidences of grades II to IV acute GVHD, extensive chronic GVHD, and non-relapse mortality (NRM), or probability of relapse between the two groups. Furthermore, the 3-yr overall survival (OS) and leukemia-free survival (LFS) were not significantly different between the older and younger groups: 67.09.3% vs. 75.3 +/- 3.4% (p=0.406) and 60.5 +/- 9.6% vs. 72.5 +/- 3.5% (p=0.183), respectively.

ConclusionSelected older patients aged 50yr with low HCT-CI and good performance status could safely undergo haploidentical SCT.

语种英语
WOS记录号WOS:000356017700007
项目编号Z121107002612035
资助机构Bejing Municipal Science &amp ; Technology Commission
引用统计
被引频次:7[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/52288
专题北京大学第二临床医学院_血液科
作者单位1.Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China
2.Peking Univ, Inst Hematol, Peoples Hosp, Beijing 6006, Peoples R China
推荐引用方式
GB/T 7714
Chen, Yao,Wang, Yu,Xu, Lan-Ping,et al. Haploidentical stem cell transplantation in patients aged 50yr and older with leukemia: similar outcomes compared to younger adults[J]. CLINICAL TRANSPLANTATION,2015,29(6):523-530.
APA Chen, Yao.,Wang, Yu.,Xu, Lan-Ping.,Liu, Kai-Yan.,Chen, Huan.,...&Huang, Xiao-Jun.(2015).Haploidentical stem cell transplantation in patients aged 50yr and older with leukemia: similar outcomes compared to younger adults.CLINICAL TRANSPLANTATION,29(6),523-530.
MLA Chen, Yao,et al."Haploidentical stem cell transplantation in patients aged 50yr and older with leukemia: similar outcomes compared to younger adults".CLINICAL TRANSPLANTATION 29.6(2015):523-530.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Chen, Yao]的文章
[Wang, Yu]的文章
[Xu, Lan-Ping]的文章
百度学术
百度学术中相似的文章
[Chen, Yao]的文章
[Wang, Yu]的文章
[Xu, Lan-Ping]的文章
必应学术
必应学术中相似的文章
[Chen, Yao]的文章
[Wang, Yu]的文章
[Xu, Lan-Ping]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。